COMMUNIQUÉS West-GlobeNewswire

TG Therapeutics, Inc. Recaps Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association
01/06/2018
NEW YORK, June 01, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today recapped the schedule of data presentations at the upcoming 54 th Annual Meeting of the American Society of Clinical Oncology (ASCO [...]
Myriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
01/06/2018
riskScore Provides Women Who Test Negative for Hereditary Breast Cancer Mutations Definitive Information about their 5-Year and Lifetime Risk of Breast Cancer SALT LAKE CITY, June 01, 2018 (GLOBE NEWSWIRE) -- Myriad [...]
MPI - Clinical data on PARP inhibitor 2X-121 and DRP response prediction validation to be presented on the world's largest cancer congress ASCO 2018
01/06/2018
Hoersholm, Denmark, June 1, 2018 - Medical Prognosis Institute A/S ("MPI") hereby announces that clinical data on PARP inhibitor 2X-121 and DRP response prediction validation is to be presented on the world's largest [...]
ObsEva SA to Seek SIX Share Listing
01/06/2018
Geneva, Switzerland and Boston, MA -June 1, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that [...]
Summit Therapeutics plc : Notice of 1st Quarter Results
01/06/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018 Oxford, UK, and Cambridge, MA, US, 1 June 2018 - Summit [...]
Shire plc : Total voting rights
01/06/2018
Total Voting Rights June 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]
As Anticipated, Sarepta Receives Negative CHMP Opinion for EXONDYS® (eteplirsen) to Treat Patients with Duchenne Muscular Dystrophy in Europe
01/06/2018
-- Sarepta will seek re-examination of the opinion and request that a Scientific Advisory Group (SAG) be convened -- CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a [...]
Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018
01/06/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT) will announce its financial results for the first quarter ended 30 April 2018 on 5 June [...]
BeiGene to Present Data on Zanubrutinib and Host an Investor Call from the 23rd Congress of the European Hematology Association
01/06/2018
BEIJING, China and CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018
LEXINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare [...]
Amicus Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference
01/06/2018
CRANBURY, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics , Inc. (Nasdaq:FOLD) announced today that John F. Crowley, Chairman and Chief Executive Officer, will participate in a corporate overview and [...]
Avivagen Announces Distribution in China for Vivamune
01/06/2018
OTTAWA, June 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
01/06/2018
Inclusion in the Cancer Drugs Fund will give more women in England and Wales with recurrent, platinum-sensitive ovarian cancer access to ZEJULA via a managed access arrangement ZEJULA was launched in the private market [...]
Mauricio Graber commences as new CEO of Chr. Hansen Holding A/S
01/06/2018
Company Announcement No.10/2018 Attachment No 10 2018 US_new CEO
Solon Eiendom ASA : Primary insider notification
01/06/2018
(Oslo, Norway, May 31, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 9.366 shares in Solon Eiendom ASA at a price of NOK 30.00. Following this [...]
Shire plc : Rule 2.9 Announcement
01/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 June 2018 Shire [...]
DBV Technologies: Ordinary and Extraordinary General Meeting of June 22, 2018 - Procedures for Obtaining Preparatory Documents for the General Meeting
01/06/2018
Montrouge, France, June 1, 2018 Ordinary and Extraordinary General Meeting of June 22, 2018 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - [...]
DBV Technologies : Assemblée Générale Mixte du 22 juin 2018 - Modalités de mise à disposition des documents préparatoires à l'Assemblée
01/06/2018
Montrouge, France, le 1 juin (07h30 CEST) 2018 Assemblée Générale Mixte du 22 juin 2018 Modalités de mise à disposition des documents préparatoires à l'Assemblée DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - [...]
Vericel Corporation Prices $65 Million Public Offering of Common Stock
01/06/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its [...]

Pages